Erik Cobo Valeri

About Erik Cobo Valeri

Erik Cobo Valeri, With an exceptional h-index of 36 and a recent h-index of 27 (since 2020), a distinguished researcher at Universidad Politécnica de Cataluña, specializes in the field of Causality, Constant Effect, Reproducibility, Reporting Guidelines, Trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

Medicina Clínica: A commitment to improvement.

Medicina Clínica: un compromiso con la mejora

Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: A systematic review

Development and validation of a postprocedural model to predict outcome after endovascular treatment for ischemic stroke

Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial

APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

Estadística y salud: principios metodológicos en las guías de publicación

Erik Cobo Valeri Information

University

Position

___

Citations(all)

11415

Citations(since 2020)

5607

Cited By

8120

hIndex(all)

36

hIndex(since 2020)

27

i10Index(all)

73

i10Index(since 2020)

48

Email

University Profile Page

Google Scholar

Erik Cobo Valeri Skills & Research Interests

Causality

Constant Effect

Reproducibility

Reporting Guidelines

Trials

Top articles of Erik Cobo Valeri

Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

The AAPS Journal

2024/4/17

Medicina Clínica: A commitment to improvement.

Medicina Clinica

2024/2/19

Medicina Clínica: un compromiso con la mejora

2024/2/19

Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: A systematic review

2024/2/1

Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial

JAMA neurology

2023/8/1

APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

Frontiers in neurology

2023/2/24

Estadística y salud: principios metodológicos en las guías de publicación

2023

Erik Cobo Valeri
Erik Cobo Valeri

H-Index: 22

Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in …

Jama

2022/5/10

Descripción de la supervivencia con indicadores numéricos y gráficos. Conceptos básicos y errores que evitar

Cir. Esp.(Ed. impr.)

2022

Guadalupe Gómez Melis
Guadalupe Gómez Melis

H-Index: 16

Erik Cobo Valeri
Erik Cobo Valeri

H-Index: 22

An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2× 2 crossover designs

Biometrical Journal

2021/1

Buenas prácticas en la metodología de la investigación clínica

2021/12/1

Valorar la predicción

Medicina Clínica Práctica

2021/12/1

Magnitud del efecto

Medicina Clínica Práctica

2021/12/1

Significados de prospectivo y retrospectivo

Medicina Clínica Práctica

2021/12/1

Constant effect in randomized clinical trials with quantitative outcome: A methodological review

2021/5/27

BIOESTADÍSTICA (Examen 1r quadrim)

2021/3/25

Erik Cobo Valeri
Erik Cobo Valeri

H-Index: 22

Effect of an editorial intervention to improve the completeness of reporting of randomised trials: a randomised controlled trial

BMJ open

2020/5/1

See List of Professors in Erik Cobo Valeri University(Universidad Politécnica de Cataluña)

Co-Authors

academic-engine